Oragenics gains NYSE American approval of compliance plan; listed with 'BC' indicator through Oct 2025

ORAGENICS INC

NYSE American accepted Oragenics' plan to regain compliance with continued listing standards by October 18, 2025.
Company must make progress and is subject to quarterly monitoring; if not, delisting proceedings may initiate after Oct 18, 2025.
During plan period, stock trades under symbol OGEN with '.BC' indicator.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.